
Board Meeting3 Nov 2026, 06:52 pm
Alkosign Ltd Board Meeting on Nov 13, 2026 for Financial Results
AI Summary
Alkosign Ltd has announced that its Board of Directors will convene on November 13, 2026. The primary agenda item is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the half-year ended September 30, 2026, along with the Limited Review Report. Additionally, the company has confirmed the closure of its trading window from October 1, 2026, until 48 hours after the financial results are communicated to the stock exchange, in compliance with SEBI's Insider Trading Regulations.
Key Highlights
- Board meeting scheduled for November 13, 2026.
- To approve Unaudited Standalone and Consolidated Financial Results.
- Results for the half-year ended September 30, 2026, will be reviewed.
- Trading window remains closed until results announcement.
Price Impact
More from ALKOSIGN